Objectives Heterozygous familial hypercholesterolaemia (FH) confers a significant risk for
premature cardiovascular disease (CVD). However, the estimated prevalence of FH varies …

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban
and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a …

Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management,
multidisciplinary teamwork, involvement of primary care practitioners, patient networks …

Background: Genetic screening programs in unselected individuals with increased levels of
low-density lipoprotein cholesterol (LDL-C) have shown modest results in identifying …

Background Although familial hypercholesterolemia (FH) is a severe monogenic disease, it
has been shown that clinical risk factors and common genetic variants can modify …

Introduction Guidelines advise ongoing follow-up of patients after hypertensive disorders of
pregnancy (HDP) to assess cardiovascular risk and manage future patient-specific …

Importance Many pediatric patients with heterozygous familial hypercholesterolemia (HeFH)
cannot reach recommended low-density lipoprotein cholesterol (LDL-C) concentrations on …

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban
and rural residents in China, and elevated low-density lipoprotein cholesterol (LDL-C) is a …

Background Current data from individual studies present conflicting evidence about the
relationship between risk factors and cardiovascular disease (CVD) in heterozygous familial …

Background and aims Familial hypercholesterolaemia (FH) is widely underdiagnosed.
Cascade testing (CT) of relatives has been shown to be feasible, acceptable and cost …